TransMedics Group, Inc. (TMDX): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$394.81M
As of 2023-12-31
+152.3%
3-year compound annual growth
+81.1%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $394.81M | +96.2% | 2024-02-27, Balance as of period end |
| 2022-12-31 | $201.18M | +686.5% | 2024-02-27, Balance as of period end |
| 2021-12-31 | $25.58M | +4.1% | 2024-02-27, Balance as of period end |
| 2020-12-31 | $24.58M | +22.3% | 2023-02-27, Balance as of period end |
| 2019-12-28 | $20.09M | -0.7% | 2021-03-11, Balance as of period end |
| 2018-12-29 | $20.24M | n/a | 2020-03-17, Balance as of period end |